早期脉冲甲泼尼龙与静脉免疫球蛋白对皮肌炎和多发性肌炎的长期影响
该回顾性单中心队列研究纳入204例PM/DM患者,评估诊断第一年内使用脉冲IVMP或IVIG对完全临床应答、糖皮质激素停用和生存的影响。多变量分析显示,早期脉冲IVMP及IVMP+IVIG组完全临床应答的HR较高,仅IVMP+IVIG组与激素停用显著相关,早期治疗对死亡率无影响。
要点
- 早期脉冲IVMP或IVMP+IVIG与更高的完全临床应答率相关。
- 仅脉冲IVMP+IVIG联合方案与糖皮质激素停用显著相关。
- 早期脉冲IVMP或IVIG对死亡率无影响。
核心结论
- 尽管病情更重,诊断第一年内接受脉冲IVMP或IVMP+IVIG的PM/DM患者完全临床应答的HR更高。
- 脉冲IVMP+IVIG联合方案与糖皮质激素停用相关,早期脉冲IVMP或IVIG对死亡率无影响。
研究设计与样本
- 回顾性单中心队列研究,纳入2001至2017年随访至多4年的PM/DM患者204例。
- 采用Cox回归模型估计HR,并调整临床、实验室和治疗协变量。
主要发现
- 早期脉冲IVMP组完全临床应答的多变量HR=1.56(95%CI:1.05,2.33,P=0.029)。
- 早期脉冲IVMP+IVIG组完全临床应答的多变量HR=1.58(95%CI:1.02,2.45,P=0.041)。
- 仅脉冲IVMP+IVIG组与激素停用显著相关(HR=1.65,95%CI:1.02,2.68,P=0.043)。
- 早期脉冲IVMP或IVIG对死亡率无影响。
关键数值与推荐
- 初始治疗分组:脉冲IVMP组46例,脉冲IVMP+IVIG组55例,IVIG组10例,无IVMP或IVIG组93例。
临床怎么用
- 对病情较重的PM/DM患者,诊断第一年内可考虑早期脉冲IVMP或IVMP+IVIG以促进完全临床应答。
- 若期望提高糖皮质激素停用机会,脉冲IVMP+IVIG联合方案可能更有优势。
局限性
- 回顾性单中心设计,结果需前瞻性长期研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the long-term effects of pulse i.v. methylprednisolone (IVMP) or IVIG administered during the first year of diagnosis in DM and PM patients. METHODS: This is a retrospective single-centre cohort study of patients with PM/DM followed for up to 4 years from 2001 to 2017. We used Cox regression models to estimate hazard ratios (HRs) and assess the effects of early pulse IVMP or IVIG on three outcomes: complete clinical response, CS discontinuation, and survival. Analysis was adjusted for clinical, laboratory and treatment covariates. RESULTS: A total of 204 patients were included and categorized into four initial treatment groups: pulse IVMP (n = 46), pulse IVMP + IVIG (n = 55), IVIG (n = 10), and without IVMP or IVIG (n = 93). The groups of early pulse IVMP and pulse IVMP + IVIG had a higher HR for complete clinical response in the multivariate models (HR = 1.56, 95% CI: 1.05, 2.33, P = 0.029; and HR = 1.58, 95% CI: 1.02, 2.45, P = 0.041, respectively). Only the group of pulse IVMP + IVIG had a significant association with CS discontinuation in the multivariate analysis (HR = 1.65, 95% CI: 1.02, 2.68, P = 0.043). Early pulse IVMP or IVIG had no impact on mortality. CONCLUSION: Despite having a more severe disease profile, patients with PM/DM submitted to pulse IVMP or pulse IVMP + IVIG during the first year of diagnosis had a higher HR for complete clinical response, whereas the combination of pulse IVMP + IVIG had an association with CS discontinuation. Prospective long-term studies are warranted to confirm these benefits of early pulse IVMP and IVIG on patients with PM/DM.
引用
- Hoff LS, de Souza FHC, Miossi R, et al. Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis. Rheumatology (Oxford). 2022. PMID: 34302454. doi:10.1093/rheumatology/keab597
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。